Experiences of predictive testing in young people at risk of Huntington's disease, familial cardiomyopathy or hereditary breast and ovarian cancer

European Journal of Human Genetics

Volumn 22, Issue 3, 2014, Pages 396-401

  MacLeod, Rhona ^a,b   Beach, Anna ^a,b   Henriques, Sasha ^a,b   Knopp, Jasmin ^a   Nelson, Katie ^a,b   Kerzin Storrar, Lauren ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

familial cardiomyopathy; hereditary breast and ovarian cancer; Huntington's disease; predictive testing; young adults

Indexed keywords

ADOLESCENT; ADULT; BREAST NEOPLASMS; CARDIOMYOPATHY, DILATED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; HUNTINGTON DISEASE; MALE; OVARIAN NEOPLASMS; PARENTS; PATIENTS; SELF REPORT;

EID: 84894361732     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2013.143     Document Type: Article

References (26)

1. Semaka A, Creighton S, Warby S, Hayden MR: Predictive testing for Huntington disease: interpretation and significance of intermediate alleles. Clin Genet 2006; 70: 283-294.
2. Maron BJ, Maron MS, Semsarian C: Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. J Am Coll Cardiol 2012; 21: 705-715.
3. Meric-Bernstam F, Gutierrez-Barrera AM, Litton J et al: Genotype in BRCA-associated breast cancers. Breast J 2013; 19: 87-91.
4. European Society of Human Genetics. Genetic testing in asymptomatic minors: recommendations of the European Society of Human Genetics. Eur J Hum Genet 2009; 17: 720-721.
5. Broadstock M, Michie S, Marteau T: Psychological consequences of predictive genetic testing: a systematic review. Eur J Hum Genet 2000; 8: 731-738.
6. Decruyenaere M, Evers-Kiebooms G, Cloostermans T et al: Psychological distress in the 5-year period after predictive testing for Huntington's disease. Eur J Hum Genet 2003; 11: 30-38.
7. Meiser B: 'Psychological impact of genetic testing for cancer susceptibility: an update of the literature'. Psych Onc 2005; 14: 1060-1074.
8. Gargiulo M, Lejeune S, Tanguy M-L et al: Long-term outcome of presymptomatic testing in Huntington disease. Eur J Hum Genet 2009; 17: 165-171.
9. Timman R, Roos R, Maat-Kievit A, Tibben A: Adverse effects of predictive testing for Huntington disease underestimated: long term effects 7-10 years after the test. Health Psychol 2004; 17: 165-171.
10. Sobel SK, Cowan DB: Impact of genetic testing for Huntington disease on the family system. Am J Med Genet 2000; 90: 49-59.
11. Nycum G, Avard D, Knoppers BM: Factors influencing intrafamilial communication of hereditary breast and ovarian cancer genetic information. Eur J Hum Genet 2009; 17: 872-880.
12. Bombard Y, Palin J, Friedman JM et al: Canadian respond-HD collaborative research group. Factors associated with experiences of genetic discrimination among individuals at risk for Huntington disease. Am J Med Genet B Neuropsychiatr Genet 2011; 156B: 19-27.
13. Duncan RE, Gillam L, Savulescu J et al: "You're one of us now": Young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP). Am J Med Genet (Semin Med Genet) 2008; 148C: 47-55.
14. Duncan RE, Gillam L, Savulescu J, Williamson R, Rogers JG, Delatycki MB: The challenge of developmentally appropriate care: predictive genetic testing in young people for familial adenomatous polyposis. Fam Cancer 2010; 9: 27-35.
15. Werner-Lin A, Hoskins LM, Doyle MH, Greene MH: Werner-Lin. 'Cancer doesn't have an age': genetic testing and cancer risk management in BRCA1/2 mutation-positive women aged 18-24. Health 2012; 16: 636-654.
16. Hoskins LM, Roy KM, Greene MH: Toward a new understanding of risk perception among young female BRCA1/2 'previvors'. Families, Systems & Health 2012; 30: 32-46.
17. Meulenkamp TM, Tibben A, Mollema ED et al: Predictive genetic testing for cardiovascular diseases: impact on carrier children. Am J Med Genet 2008; 146A: 3136-3146.
18. MacLeod R, Tibben A, Frontali M et al: Recommendations for the predictive genetic test in Huntington's Disease. Clin Genet 2013; 83: 221-223.
19. Smith JA, Osborn M: Interpretative Phenomenological Analysis; In Smith JA (ed) Qualitative Psychology: A Practical Guide to Methods. London: Sage. 2nd (edn), 2008.
20. Smith JA, Jarman M, Osborne M: Doing Interpretative Phenomenological Analysis; In Murray M, Chamberlain K (eds) Qualitative Health Psychology: Theories and Methods. London: Sage, 1999; pp l218-l240.
21. Wilson K, Roe B, Wright L: Telephone or face-to-face interviews? a decision made on the basis of a pilot study. Int J of Nurs Stud 1998; 35: 314-321.
22. Carr ECG, Worth A: The use of the telephone interview for research. Nurs Times Res 2001; 6: 511-524.
23. Wright C, Kerzin-Storrar L, Williamson PR et al: Comparison of genetic services with and without genetic registers: knowledge, adjustment and attitudes about genetic counselling among probands referred to three genetic clinics. J Med Genet 2002; 39: e84.
24. Kerzin-Storrar L, Wright C, Williamson PR et al: Comparison of genetic services with and without genetic registers: access and attitudes to genetic counselling services among relatives of genetics clinic patients. J Med Genet 2002; 39: e85.
25. Wilding A, Ingham SL, Lalloo F: Life expectancy in hereditary cancer predisposing diseases: an observational study. J Med Genet 2012; 49: 264-269.
26. Hamilton R: Being young, female, and BRCA positive. Am J Nurs 2012; 112: 26-31.